FAQs & Resources.

FAQs & Resources.

Everything You Need to Know About ADVATx®

Whether you're considering ADVATx® for the first time or looking for more details, find answers to common questions, real patient results, and key resources to help you make an informed decision.

 FAQs

  • Yes! ADVATx® is FDA/CE-cleared for acne and the appearance of acne scarring among 25 indications.

  • ADVATx® is suitable for skin types I–V and ideal for those with active acne, inflammation, and acne scarring. It’s also an option for individuals who have not responded to other treatments or prefer to avoid long-term oral medications and harsh topicals.

  • Unlike oral medications like isotretinoin (Accutane) and antibiotics, ADVATx® is a non-medicated treatment that doesn’t require routine bloodwork or long-term prescriptions. It works by addressing key acne triggers — bacteria, inflammation, and oil production — without the potential side effects of traditional acne drugs.

  • While results vary, many patients see noticeable improvements in skin clarity after just a few treatments. Sessions usually last under 30 minutes, making it an easy addition to any skincare routine. A personalized treatment plan will depend on the severity of acne and individual skin goals.

  • ADVATx® is a non-invasive laser treatment that doesn’t require numbing and is well tolerated by most patients. You may feel a warm sensation during the session, but discomfort is typically minimal compared to other laser treatments.

  • ADVATx® has no social downtime, meaning you can return to your routine immediately after treatment. Unlike some lasers that cause prolonged redness or peeling, ADVATx® delivers results without disrupting your daily life.

Before & After Results: Transformations You Can Trust

See the difference. ADVATx® helps reduce inflammation, calm active breakouts, and refine skin texture all with no social downtime.

Latest on the Blog: Trends, Tips & More |

Latest on the Blog: Trends, Tips & More |

For a deeper dive into all things ADVATx®, explore our latest blog posts: